此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Laparoscopic Versus Open Resection of Cancer Stomach

2020年9月6日 更新者:Mohamed Gamal Ameen Taher、Assiut University

Laparoscopic Versus Open Resection of Cancer Stomach Randomized Controlled Trial

The aim of surgical procedures for resection of cancer stomach is to resection of the tumor mass with safety margin and its drainage lymph nodes (lymphadenectomy).

There are two main types of techniques (open & laparoscopic) Many studies were done comparing these two techniques showed that Laparoscopic resection is superior in early postoperative recovery (less pain ,less bleeding and shorter hospital stay) but less radical than open resection (less safety margin & less lymphadenectomy) but because of the ongoing advances on laparoscopic surgery these results needs more and more revision.

So the investigators conduct this randomized controlled trial aiming at comparing open and laparoscopic resection of cancer stomach to choose the best surgical procedure for resection of cancer stomach.

研究概览

详细说明

The surgical procedure for resection of cancer stomach aiming at resection of the tumor mass with safety margin and its drainage lymph nodes (lymphadenectomy).

# Tumor resection;

Will be done by one of the following techniques:

  1. laparoscopic gastrectomy (totally laparoscopic, laparoscopy-assisted, and hand-assisted) types of gastrectomy (according to site of tumour)
  2. Open gastrectomy (according to the site of tumor). # Lymphadenectomy; Will be done according to Japanese Gastric Cancer Association guidelines for optimal lymph node dissection levels for Early Gastric Cancer (1):

    • D1+alpha -(perigastric lymph node dissection) for mucosal cancer, for which EMR is not indicated and for histologically differentiated submucosal cancer of < 1.5 cm in diameter;
    • D1+ beta for preoperatively diagnosed submucosal cancer without lymph node metastasis (N0), for which D1+ alpha is not indicated, and for early cancer < 2.0 cm in diameter with only perigastric lymph node metastasis (N1);
    • D2 for early cancer > 2.0 cm in diameter. Follow up: all patients will be followed up clinically for the outcomes for each surgical technique.

研究类型

介入性

注册 (实际的)

73

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Assiut、埃及
        • Assiut university hospitals

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • All patients with primary carcinoma of the stomach, where the tumor is considered surgically resectable (T1-3, N0-1, M0).

Exclusion Criteria:

  • Pregnancy.
  • Infiltration to the( pancreas ,liver ,colon or vital vascular structure).
  • Metastasis to the (liver, lung, brain, paraaortic LN involvement).
  • Peritoneal deposit.
  • Surgically unfit patient.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Laparoscopic gastrectomy
Patients allocated to the 'laparoscopic Gastrectomy' group will undergo laparoscopic gastrectomy. If, during surgery, laparoscopic resection does not seem feasible, the procedure may be converted to an open one.
Patients allocated to the 'laparoscopic gastrectomy' arm will receive gastrectomy via laparoscopy.
其他名称:
  • Minimally invasive gastrectomy
有源比较器:Open gastrectomy
Patients allocated to the 'Open Gastrectomy' group will receive gastrectomy via laparotomy. This group is considered the control group
patients allocated to the 'Open gastrectomy' group will receive gastrectomy via laparotomy

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
The number of lymph nodes in the postoperative spicement.
大体时间:two weeks
considered a prognostic factor for disease-free postoperative survival The more the number of lymph nodes the more radicality of the procesure
two weeks

次要结果测量

结果测量
措施说明
大体时间
死亡
大体时间:术后30天
以 30 天死亡率衡量
术后30天
Postoperative complications
大体时间:Postoperatively with follow-up to one year
Complications will be graded according to the Clavien-Dindo classification, which grades complications with regard to necessary treatment for this complication. Also Long-term complications, such as hernia cicatricialis will be monitored
Postoperatively with follow-up to one year
Peri-operative blood loss
大体时间:during surgery, 1 day
Laparoscopic gastrectomy is associated with less peri-operative blood loss. Blood loss will be measured in milliliters and compared to the conventional 'open' group.
during surgery, 1 day
Duration of Surgery
大体时间:Peri-operatively, 1 day
UsuallyLaparoscopic gastrectomy takes longer time to complete. The duration of the procedure will be registered in minutes.
Peri-operatively, 1 day

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 研究主任:Mostafa A Hamad, Prof.、Assiut University- Faculty of Medicine
  • 研究主任:Mostafa M Sayed、Assiut University- Faculty of Medicine
  • 首席研究员:Mohamed G Taher、Assiut University- Faculty of Medicine- General surgery department

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2016年6月1日

初级完成 (实际的)

2019年12月1日

研究完成 (实际的)

2020年1月1日

研究注册日期

首次提交

2016年5月22日

首先提交符合 QC 标准的

2016年5月29日

首次发布 (估计)

2016年6月3日

研究记录更新

最后更新发布 (实际的)

2020年9月9日

上次提交的符合 QC 标准的更新

2020年9月6日

最后验证

2020年9月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

3
订阅